Everything you need to know about using Finasteride and Minoxidil together
- How the two medicines work together
- What the clinical evidence shows
- Delivery formats available in the UK, including the growing range of combination topical products
- Side effects when combining both: What to monitor and what to report
- Results timelines and realistic expectations at 3, 6, and 12 months
- Who is and is not a good candidate
- UK prescription access and cost
What the clinical evidence shows
The evidence base for combination therapy has grown considerably in recent years and now includes multiple randomised controlled trials and meta-analyses.
A 2025 meta-analysis published in Frontiers in Medicine, reviewing seven randomised controlled trials involving 396 patients, demonstrated superior efficacy of topical minoxidil-finasteride combination over minoxidil monotherapy for male androgenetic alopecia. Pooled analyses showed clinically meaningful improvements in hair density, hair diameter, and global photographic assessment, all exceeding minimal clinically important thresholds.
The treatment effect followed a hierarchical pattern, with the combination showing the strongest benefits for marked improvement. Short-term studies of 12 weeks often showed no significant benefit over monotherapy, whereas longer trials of 24 weeks or more suggested improved efficacy with the combination at higher concentrations.
A 2024 prospective randomised controlled trial published in the Journal of Cosmetic Dermatology compared topical 5% minoxidil plus 0.25% topical finasteride against each medicine used alone over six months. The study confirmed that minoxidil and finasteride act through different mechanisms and that their combination could improve clinical efficacy compared to either used as monotherapy.
The clinical takeaway is clear: combination therapy produces better outcomes than either medicine alone for most men, and the benefit becomes more pronounced over time rather than in the short term.
Delivery formats available in the UK
Finasteride and minoxidil can be combined in several ways in UK clinical practice.
Oral finasteride plus topical minoxidil is the most established combination. Finasteride 1 mg is taken orally once daily alongside topical minoxidil 5% solution or foam which is applied to the scalp once or twice daily. Both are well characterised individually with long-term safety data.
Topical combination spray or solution: A growing number of licensed compounding pharmacies and private providers offer a single topical product containing both finasteride and minoxidil, typically at concentrations of 0.1% finasteride and 5% minoxidil. This format delivers both medicines directly to the scalp, potentially reducing systemic finasteride exposure compared to oral tablets. Topical finasteride was developed to minimise the systemic adverse effects associated with the oral formulation. These products are not MHRA-licensed as fixed-dose combination medicines and are prepared as specials, but are available through regulated UK compounding pharmacies under prescriber supervision.
Oral minoxidil plus oral finasteride: Some prescribers offer this combination for patients who find topical application inconvenient. Both medicines are prescribed at low doses. This approach requires careful monitoring and is appropriate only for patients who have been assessed as suitable for oral minoxidil.
Important !
Finasteride is a prescription-only medicine (POM) in the UK regardless of the formulation or delivery route. Any product containing finasteride, including combination topical sprays, requires a valid prescription from a UK-registered prescriber. Do not purchase combination products from unregulated online sources where the concentration, purity, and sterility of the product cannot be verified.
Side effects when combining both medicines
Finasteride and minoxidil act through entirely different mechanisms, which means their side effects are largely separate rather than compounding each other.
From finasteride (oral): The most commonly discussed side effects are sexual, including reduced libido, erectile dysfunction, and ejaculatory disorders, reported in a subset of men. These are pharmacologically plausible given finasteride's mechanism and are reversible on stopping in most cases. Post-finasteride syndrome has been reported but remains a subject of ongoing research. Mood changes have also been reported. A prescriber should discuss these risks in detail before starting.
From minoxidil (topical): Scalp irritation, initial shedding in the first two to eight weeks, and the low risk of facial hair growth with inadvertent skin contact. These are generally mild and manageable.
From topical combination products: Using a combined topical product rather than oral finasteride may reduce the systemic side effects from finasteride, as scalp absorption produces lower blood levels than the oral tablet. Sexual side effects are reported less frequently with topical finasteride in available studies, though the evidence base is smaller than for oral finasteride.
Important !
If you experience any sexual side effects, mood changes, or breast changes while taking finasteride in any form, contact your prescriber promptly. Do not stop the medication without speaking to your prescriber first.
Report any suspected side effects from either medicine to the MHRA via the Yellow Card scheme.
Results timeline and what to expect
Hair loss treatment requires patience. The following is a realistic guide based on clinical trial data.
| Timeframe | What typically happens |
|---|---|
| Month 1 to 2 | Possible initial shedding from minoxidil; no visible regrowth yet |
| Month 3 | Early stabilisation of hair loss; some patients notice reduced shedding |
| Month 6 | Visible improvement in hair density and diameter in most responders; clinical trials show this is when combination benefits over monotherapy become more pronounced |
| Month 12 | More significant hair density improvements |
| Beyond 12 months | Continued gradual improvement; treatment must be maintained to sustain results |
Good to know
Neither finasteride nor minoxidil produces results overnight. The hair growth cycle operates over months rather than weeks, and meaningful visible improvement typically requires at least six months of consistent treatment. Stopping early is the most common reason for poor outcomes.
Who is a good candidate for combination therapy?
Combination therapy is most appropriate for men who:
- Have confirmed androgenetic alopecia (male pattern hair loss) and are seeking the most effective available pharmacological approach
- Have tried monotherapy with either medicine and found the results insufficient
- Are in the early to moderate stages of hair loss, where more follicles remain active and responsive to treatment
- Have no contraindications to either medicine following a medical assessment
- Are committed to long-term, consistent treatment and follow-up
Who should not combine finasteride and minoxidil?
Combination therapy is not appropriate for everyone. Do not combine these medicines without prescriber assessment if you:
- Are considering fathering children in the near future: finasteride is teratogenic and must not be handled by pregnant women or used by men attempting conception without discussing this with a prescriber
- Have a history of low blood pressure or cardiovascular conditions, particularly if oral minoxidil is being considered alongside finasteride
- Have a history of depression or mood disorders: finasteride has been associated with mood changes in some men
- Have prostate cancer or a history of it: finasteride affects PSA levels and requires specialist input
- Are under 18 years of age: neither medicine is licensed for use in minors for hair loss
UK prescription access and cost
Both medicines require a prescription in the UK. Finasteride 1 mg is available on the NHS in some areas for androgenetic alopecia, though availability varies by region. Topical minoxidil 5% is available over the counter.
Private access to both medicines, including combination topical products, is available through GPhC-registered online clinics following a medical assessment. As a general guide for private prescription costs:
- Oral finasteride 1 mg: typically £10 to £25 per month
- Topical minoxidil 5%: typically £15 to £30 per month
- Combination topical spray (finasteride and minoxidil): typically £30 to £60 per month depending on provider
Important !
Do not purchase combination finasteride and minoxidil products from unregulated sources. Products of unverified concentration or purity carry real risks, particularly given finasteride's hormonal mechanism. Always use a GPhC-registered provider and verify registration at gphc.org.uk.
Final thoughts
The combination of finasteride and minoxidil is the most evidence-supported pharmacological approach to male androgenetic alopecia currently available in the UK. The two medicines address hair loss through different mechanisms, and the clinical evidence consistently shows better outcomes from the combination than from either medicine used alone, particularly over the longer term.
Results require patience and consistent use. If you are considering combination therapy, a medical assessment is the essential starting point to confirm suitability, discuss the side effect profile, and ensure access through a regulated prescribing pathway.
FAQ
Can you use finasteride and minoxidil together?
Yes. Combining the two medicines is supported by clinical evidence and is more effective than either used alone for male androgenetic alopecia. The mechanisms are complementary and the side effect profiles are largely independent.
Is the combination better than using one medicine alone?
A 2025 meta-analysis of seven randomised controlled trials demonstrated superior efficacy of the topical combination over minoxidil monotherapy, with clinically meaningful improvements in hair density, hair diameter, and global photographic assessment. The benefit is most pronounced in trials lasting 24 weeks or longer.
Does combining them increase side effects?
Not significantly. Because the two medicines work through different pathways, their side effects are largely independent. Using a topical combination product rather than oral finasteride may reduce systemic side effect risk from finasteride.
How long before you see results from combination therapy?
Visible improvement typically begins at around six months. Clinical trial evidence suggests the benefit of combination over monotherapy becomes more apparent at this timeframe and beyond.
Is a prescription required for combination therapy in the UK?
Yes. Finasteride is a prescription-only medicine in all its forms. Any topical combination product containing finasteride requires a valid prescription from a UK-registered prescriber.
Can women use finasteride and minoxidil together?
Finasteride is not licensed for use in women for hair loss in the UK and is contraindicated in women who are or may become pregnant. Women with hair loss should discuss appropriate treatment options with their prescriber. Topical minoxidil 2% is licensed for use in women.
The DoktorABC medical advisory board
Dr. Roland Ruiken
Medical advisor, Norway
Dr. Viktor Simunovic
Medical advisor, Croatia